Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
INTELLIGENT BIO SOLUTIONS INC. (GBS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 10/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/10/2023 |
4/A
| Sakiris Spiro Kevin (CFO) has filed a Form 4 on INTELLIGENT BIO SOLUTIONS INC. |
| 10/06/2023 |
4
| TOWERS CHRISTOPHER (Director) has filed a Form 4 on INTELLIGENT BIO SOLUTIONS INC.|
Txns:
| Bought 9,090 shares
@ $0
Bought 9,090 options to buy
@ $0 |
|
| 10/06/2023 |
4
| Sakiris Spiro Kevin (CFO) has filed a Form 4 on INTELLIGENT BIO SOLUTIONS INC.|
Txns:
| Bought 112,727 shares
@ $0
Bought 112,727 options to buy
@ $0 |
|
| 10/05/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 10/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...|
Docs:
|
"1,544,004 SHARES of Common Stock 5,728,723 Shares of Series E Convertible preferred stock 7,272,727 SERIES E Warrants AND 7,272,727 SERIES F Warrants of INTELLIGENT BIO SOLUTIONS INC. UNDERWRITING AGREEMENT October 2, 2023 Ladenburg Thalmann & Co. Inc. As the Representative of the Several underwriters, if any, named in Schedule I hereto 640 Fifth Avenue, 4th Floor 10019",
"Intelligent Bio Solutions Inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE delaware GENERAL CORPORATION LAW The undersigned, Spiro Sakiris, does hereby certify that: 1. He is the Chief Financial Officer of Intelligent Bio Solutions Inc., a Delaware corporation . 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, none of which are outstanding. 3. The following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.01 par value per share, issuable from time to time in one or more serie...",
"SERIES E COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: 8,363,636 Issue Date: October 4, 2023 CUSIP: 36151G147 ISIN: US36151G1470 THIS SERIES E COMMON STOCK PURCHASE WARRANT certifies that, for value received, CEDE & CO., or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date Shareholder Approval is received and effective and on or prior to 5:00 p.m. on the five-and-a-half year anniversary of the Issue Date but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to 8,363,636 shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Pri...",
"SERIES F COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: 8,363,636 Issue Date: October 4, 2023 CUSIP: 36151G154 ISIN: US36151G1546 THIS SERIES F COMMON STOCK PURCHASE WARRANT certifies that, for value received, CEDE & CO., or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date Shareholder Approval is received and effective and on or prior to 5:00 p.m. on the one-and-a-half year anniversary of the Issue Date but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to 8,363,636 shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Pric...",
"REPRESENTATIVE COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC. Warrant Shares: Initial Exercise Date: October 4, 2023 THIS REPRESENTATIVE COMMON STOCK PURCHASE WARRANT certifies that, for value received, or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on October 2, 2028 but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation , up to shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is issued pursuant to the Underwriting Agreement . Section 1 . Definitions . In ad...",
"Fees",
"Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering",
"Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option" |
|
| 10/04/2023 |
SC 13G
| BIGGER CAPITAL FUND L P reports a 7.5% stake in Intelligent Bio Solutions Inc. |
| 10/03/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 10/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/28/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 09/27/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/25/2023 |
8-K
| Quarterly results |
| 08/23/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/31/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 07/27/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/12/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/07/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/03/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/06/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 06/01/2023 |
3
| Ma-Ran Foundation (10% Owner) has filed a Form 3 on INTELLIGENT BIO SOLUTIONS INC. |
| 06/01/2023 |
3
| Gary W. Rollins Foundation (10% Owner) has filed a Form 3 on INTELLIGENT BIO SOLUTIONS INC. |
| 06/01/2023 |
SC 13D
| Gary W. Rollins Foundation has filed a Schedule 13D for Intelligent Bio Solutions Inc. |
| 05/31/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"Convertible Loan Conversion Agreement This Convertible Loan Conversion Agreement , dated as of May 9, 2023, is made and entered into by and among Intelligent Fingerprinting Limited, a company registered in England and Wales with company number 06409298 , Intelligent Bio Solutions Inc. , a Delaware corporation , and [●] . The Borrower, the Guarantor and the Lender are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the meanings given to them in the Share Exchange Agreement or the Restated Facility Agreement , as applicable. RECITALS A. The Borrower and the Lender entered into a facility agreement dated October 26, 2021 pursuant to which the Lenders, among other thin..." |
|
| 05/17/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
|
|
|